References
- Chan PK , HoWC, ChanMCet al. Meta-analysis on prevalence and attribution of human papillomavirus types 52 and 58 in cervical neoplasia worldwide. PLoS ONE9(9), e107573 (2014).
- Inoue M , OgawaH, MiyataM, ShiozakiH, TanizawaO. Expression of E-cadherin in normal, benign, and malignant tissues of female genital organs. Am. J. Clin. Pathol.98(1), 76–80 (1992).
- Doorbar J . Molecular biology of human papillomavirus infection and cervical cancer. Clin. Sci. (Lond.)110(5), 525–541 (2006).
- Rao PH , Arias-PulidoH, LuXYet al. Chromosomal amplifications, 3q gain and deletions of 2q33-q37 are the frequent genetic changes in cervical carcinoma. BMC Cancer4, 5 (2004).
- Grenko RT , AbendrothCS, FrauenhofferEE, RuggieroFM, ZainoRJ. Variance in the interpretation of cervical biopsy specimens obtained for atypical squamous cells of undetermined significance. Am. J. Clin. Pathol.114(5), 735–740 (2000).
- Craveiro R , CostaS, PintoDet al. TP73 alterations in cervical carcinoma. Cancer Genet. Cytogenet.150(2), 116–121 (2004).
- Boyer B , VallésAM, EdmeN. Induction and regulation of epithelial–mesenchymal transitions. Biochem. Pharmacol.60(8), 1091–1099 (2000).
- Huber MA , KrautN, BeugH. Molecular requirements for epithelial–mesenchymal transition during tumor progression. Curr. Opin. Cell Biol.17(5), 548–558 (2005).
- Wang N , HeYL, PangLJet al. Down-regulated E-cadherin expression is associated with poor five-year overall survival in bone and soft tissue sarcoma: results of a meta-analysis. PLoS ONE10(3), e0121448 (2015).
- Zlobec I , LugliA. Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget. Oncotarget1(7), 651–661 (2010).
- Nieman MT , PrudoffRS, JohnsonKR, WheelockMJ. N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J. Cell Biol.147(3), 631–644 (1999).
- Wang BJ , ZhangZQ, KeY. Conversion of cadherin isoforms in cultured human gastric carcinoma cells. World J. Gastroenterol.12(6), 966–970 (2006).
- Vergara D , MerlotB, LucotJ-Pet al. Epithelial–mesenchymal transition in ovarian cancer. Cancer Lett.291(1), 59–66 (2010).
- Vessey CJ , WildingJ, FolarinNet al. Altered expression and function of E-cadherin in cervical intraepithelial neoplasia and invasive squamous cell carcinoma. J. Pathol.176(2), 151–159 (1995).
- Wu H , LiuS, JiangD, ZengJ, GongL. Relationship of expression of cyclooxygenase-2 with p53 and E-cadherin expression in cervical carcinoma. Chinese J. Clin. Exp. Pathol.20(5), 568–571 (2003).
- Van De Putte G , KristensenGB, BaekelandtM, LieAK, HolmR. E-cadherin and catenins in early squamous cervical carcinoma. Gynecol. Oncol.94(2), 521–527 (2004).
- Liu DL , LiNP. Relationship between expression of MMP-14, VEGF, E-cadherin and the biological behaviors of cervical cancer. Acta Med. Univ. Sci. Technol. Huazhong.35(6), 774–777 (2006).
- Dursun P , YuceK, UsubutunA, AyhanA. Loss of epithelium cadherin expression is associated with reduced overall survival and disease-free survival in early-stage squamous cell cervical carcinoma. Int. J. Gynecol. Cancer17(4), 843–850 (2007).
- Wang J , MaJQ, MaR, GengXX. Expression of KAI1, E-cadherin and β-catenin in cervical carcinoma. J. Oncol.15(7), 671–674 (2009).
- Zhang RY , QiaoHZ. Correlationship between snail and E-cadherin and cervical lesions. Inner Mongolia Med. J.40(8), 908–911 (2008).
- De Méndez Morelva T , AntonioLB. Abnormal immunoexpression of cell adhesion molecules (CAMs) in cervical cancer. Int. J. Surg. Pathol.19(6), 733–742 (2011).
- Cheng Y , ZhouY, JiangWet al. Significance of E-cadherin, β-catenin, and vimentin expression as postoperative prognosis indicators in cervical squamous cell carcinoma. Hum. Pathol.43(8), 1213–1220 (2012).
- Jiang WJ , HuWP, ZhouY, TianY. Expression N-cadherin E-adherin and p63 in cervical squamous cell carcinoma and their significances. J. Clin. Exp. Pathol.28(11), 1215–1223 (2012).
- Zhao W , ZhouY, XuH, ChengY, KongB. Snail family proteins in cervical squamous carcinoma: expression and significance. Clin. Invest. Med.36(4), E223–E233 (2013).
- Wu Y , FuF, ZhouFY. The expressions of dysadherin and E-cadherin and their significance in cervical caner. J. Pract. Med.29(20), 3317–3319 (2013).
- Shen Z , ZhouY, ZhaoWD, ChengY, XuHJ, YangCM. Vimentin and E-Cadherin expression in cervical cancer and its correlation with EMT. Acta Universitatis Medicinalis Anhui.48(5), 505–507 (2013).
- Zhou X , FengZJ, HanL, HanZR, ZhangWX. E-cadherin and osteopontin expression and significance in cervical cancer patients. Chin. J. Clin. Obstet. Gynecol. (04), 357–359 (2013).
- Zhang RR , WangH, ZhangP. Expression of Twist and E-cadherin protein in cervical cancer tissue and their significance. Hainan Med. J.24(8), 1105–1107 (2013).
- Huang W , ZhuS, LiuQ, LiC, LiL. Placenta growth factor promotes migration through regulating epithelial–mesenchymal transition-related protein expression in cervical cancer. Int. J. Clin. Exp. Pathol.7(12), 8506–8519 (2014).
- Cavalcante JR , SampaioJP, Maia FilhoJTet al. Progressive loss of E-cadherin immunoexpression during cervical carcinogenesis. Acta Cir. Bras.29(10), 667–674 (2014).
- Yuan J . The study of relationship between expression of E-cadherin protein and cervical carcinoma. Int. J. Lab. Med. (08), 964–966 (2014).
- Cheng P . Expressions of FOXA2 and E-cadherin in cervical cancer and their correlation analysis. Maternal Child Health Care China (35), 5896–5899 (2014).
- Ge Y , YangYX, HuL, LiuC, ZhuJ. Expression and significance of Twist2 and E-cadherin in cervical squamous cell carcinoma. J. Int. Obstet. Gynecol. (01), 63–72 (2014).
- Wang H , FanL, WeiJet al. Akt mediates metastasis-associated gene 1 (MTA1) regulating the expression of E-cadherin and promoting the invasiveness of prostate cancer cells. PLoS ONE7(12), e46888 (2012).
- Drewelus I , GopfertC, HippelCet al. p63 antagonizes Wnt-induced transcription. Cell Cycle9(3), 580–587 (2010).
- Pecina-Slaus N . Tumor suppressor gene E-cadherin and its role in normal and malignant cells. Cancer Cell Int.3(1), 17 (2003).
- Cannito S , NovoE, Di BonzoLV, BuslettaC, ColombattoS, ParolaM. Epithelial–mesenchymal transition: from molecular mechanisms, redox regulation to implications in human health and disease. Antioxid. Redox Signal.12(12), 1383–1430 (2010).
- Tomita K , Van BokhovenA, Van LeendersGJet al. Cadherin switching in human prostate cancer progression. Cancer Res.60(13), 3650–3654 (2000).
- Qiu ZX , ZhaoS, LiL, LiWM. Prognostic value and clinicopathological significance of epithelial cadherin expression in non-small-cell lung cancer. Thoracic Cancer6(5), 589–596 (2015).
- Yu L , ZhouL, WuS, SongW, ChengZ, GuoB. [Expressions of CD133, E-cadherin, and Snail in epithelial ovarian cancer and their clinicopathologic and prognostic implications]. Nan Fang Yi Ke Da Xue Xue Bao35(9), 1297–1302 (2015).
- Cheng D , LiangB, LiY. High TMPRSS4 expression is a predictor of poor prognosis in cervical squamous cell carcinoma. Cancer Epidemiol.37(6), 993–997 (2013).
- Yu Z , SunM, JinFet al. Combined expression of ezrin and E-cadherin is associated with lymph node metastasis and poor prognosis in breast cancer. Oncol. Rep.34(1), 165–174 (2015).
- Yun JA , KimSH, HongHKet al. Loss of E-cadherin expression is associated with a poor prognosis in stage III colorectal cancer. Oncology86(5–6), 318–328 (2014).
- Di Bartolomeo M , PietrantonioF, PellegrinelliAet al. Osteopontin, E-cadherin, and β-catenin expression as prognostic biomarkers in patients with radically resected gastric cancer. Gastric Cancer doi: 10.1007/s10120-015-0495-y (2015) ( Epub ahead of print).
- De Craene B , BerxG. Regulatory networks defining EMT during cancer initiation and progression. Nat. Rev. Cancer13(2), 97–110 (2013).
- Ye Y , TianH, LangeAR, YearsleyK, RobertsonFM, BarskySH. The genesis and unique properties of the lymphovascular tumor embolus are because of calpain-regulated proteolysis of E-cadherin. Oncogene32(13), 1702–1713 (2013).
- Sun H , LiuX, LiM. [E-cadherin expression and its clinical significance in cervical cancer]. Zhonghua Zhong Liu Za Zhi22(6), 496–498 (2000).
- Mayer A , HockelM, SchlischewskyN, SchmidbergerH, HornLC, VaupelP. Lacking hypoxia-mediated downregulation of E-cadherin in cancers of the uterine cervix. Br. J. Cancer108(2), 402–408 (2013).
- Sun NX , YeC, ZhaoQet al. Long noncoding RNA-EBIC promotes tumor cell invasion by binding to EZH2 and repressing E-cadherin in cervical cancer. PLoS ONE9(7), e100340 (2014).